Ian K. Patel - 11 Mar 2022 Form 4 Insider Report for CEA Industries Inc. (CEAD)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
17 Mar 2022, 08:25:34 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ian K. Patel

Key filing fact

Ian K. Patel filed Form 4 for CEA Industries Inc. (CEAD) on 17 Mar 2022.

Key facts

  • This page summarizes Ian K. Patel's Form 4 filing for CEA Industries Inc. (CEAD).
  • 4 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 17 Mar 2022, 08:25.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CEAD transaction Derivative

Option to purchase common stock

Award

Transaction value
Shares
+2,000
Change %
Price
Shares after
2,000
Date
11 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,000
Exercise price
$2.20
Footnotes
F1
CEAD transaction Derivative

Option to purchase common stock

Award

Transaction value
Shares
+3,000
Change %
Price
Shares after
3,000
Date
11 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,000
Exercise price
$2.20
Footnotes
F2
CEAD transaction Derivative

Option to purchase common stock

Award

Transaction value
Shares
+5,000
Change %
Price
Shares after
5,000
Date
11 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$2.20
Footnotes
F3
CEAD transaction Derivative

Option to purchase common stock

Award

Transaction value
Shares
+5,000
Change %
Price
Shares after
5,000
Date
11 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$2.20
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the grant of non-qualified stock options to purchase 2,000 shares of common stock at an exercise price of $2.20, the closing price of the Issuer's common stock on March 10, 2022, which were vested and exercisable on the date of grant. These options were granted in connection with the Reporting Person's appointment as the Company's CFO, Treasurer and Secretary. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.

Footnote F2

Represents the grant of non-qualified stock options to purchase 3,000 shares of common stock at an exercise price of $2.20, the closing price of the Issuer's common stock on March 10, 2022, which were vest and become exercisable on March 11, 2023. These options were granted in connection with the Reporting Person's appointment as the Company's CFO, Treasurer and Secretary. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.

Footnote F3

Represents the grant of non-qualified stock options to purchase 5,000 shares of common stock at an exercise price of $2.20, the closing price of the Issuer's common stock on March 10, 2022, which were vest and become exercisable on March 11, 2024. These options were granted in connection with the Reporting Person's appointment as the Company's CFO, Treasurer and Secretary. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.

Footnote F4

Represents the grant of non-qualified stock options to purchase 5,000 shares of common stock at an exercise price of $2.20, the closing price of the Issuer's common stock on March 10, 2022, which were vest and become exercisable on March 11, 2025. These options were granted in connection with the Reporting Person's appointment as the Company's CFO, Treasurer and Secretary. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .